Brian K Young

Array ( [id] => 9970962 [patent_doc_number] => 09017968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Means and methods for producing authentic human basic fibroblast growth factor' [patent_app_type] => utility [patent_app_number] => 13/672853 [patent_app_country] => US [patent_app_date] => 2012-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7677 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799456 [patent_doc_number] => 20150011400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'Bacterial Metastructure and Methods of Use' [patent_app_type] => utility [patent_app_number] => 14/356588 [patent_app_country] => US [patent_app_date] => 2012-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13436 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792086 [patent_doc_number] => 20130109055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'USE OF MAMMALIAN PROMOTERS IN FILAMENTOUS FUNGI' [patent_app_type] => utility [patent_app_number] => 13/665609 [patent_app_country] => US [patent_app_date] => 2012-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17286 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13665609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8865996 [patent_doc_number] => 20130149699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'Translation Kinetic Mapping, Modification and Harmonization' [patent_app_type] => utility [patent_app_number] => 13/664252 [patent_app_country] => US [patent_app_date] => 2012-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20636 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13664252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822097 [patent_doc_number] => 20130123142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPRISING NAD GLYCOHYDROLASE INHIBITOR AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 13/656039 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5092 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8755957 [patent_doc_number] => 20130090262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'SELECTIVE ENRICHMENT OF CpG ISLANDS' [patent_app_type] => utility [patent_app_number] => 13/633285 [patent_app_country] => US [patent_app_date] => 2012-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12439 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8821504 [patent_doc_number] => 20130122549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'RECOMBINANT PHAGE AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/627060 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24904 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13627060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8767974 [patent_doc_number] => 20130096012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'METHOD AND KIT FOR IDENTIFYING A TRANSLATION INITIATION SITE ON AN MRNA' [patent_app_type] => utility [patent_app_number] => 13/625495 [patent_app_country] => US [patent_app_date] => 2012-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13886 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13625495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10939911 [patent_doc_number] => 20140342932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'FUNCTIONAL CELL SURFACE DISPLAY OF LIGANDS FOR THE INSULIN AND/OR INSULIN GROWTH FACTOR 1 RECEPTOR AND APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/345257 [patent_app_country] => US [patent_app_date] => 2012-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 45101 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9344823 [patent_doc_number] => 08663970 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-03-04 [patent_title] => 'Recombinant thermotolerant yeast with a substitute heat shock protein 104 promoter' [patent_app_type] => utility [patent_app_number] => 13/610015 [patent_app_country] => US [patent_app_date] => 2012-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5877 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13610015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10627620 [patent_doc_number] => 09345760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same' [patent_app_type] => utility [patent_app_number] => 14/343666 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 12155 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10225767 [patent_doc_number] => 20150110760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'NKP30 RECEPTOR TARGETED THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/342060 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 31800 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534868 [patent_doc_number] => 09260489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Engineered sequences to facilitate expression of antigens in Neisseria and methods of use' [patent_app_type] => utility [patent_app_number] => 14/239072 [patent_app_country] => US [patent_app_date] => 2012-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 41 [patent_no_of_words] => 19981 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9015907 [patent_doc_number] => 20130230872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'PLASMID VECTOR, METHOD FOR DETECTING GENE PROMOTER ACTIVITY, AND ASSAY KIT' [patent_app_type] => utility [patent_app_number] => 13/593912 [patent_app_country] => US [patent_app_date] => 2012-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10039 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13593912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509679 [patent_doc_number] => 20120309087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/569853 [patent_app_country] => US [patent_app_date] => 2012-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17671 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13569853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968051 [patent_doc_number] => 20140371084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'SNRNA RNU2-1 AS A TUMOR MARKER' [patent_app_type] => utility [patent_app_number] => 14/234267 [patent_app_country] => US [patent_app_date] => 2012-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2582 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866038 [patent_doc_number] => 20130149741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'METHODS FOR IMPROVED PRODUCTION OF BIOACTIVE WNT PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/538755 [patent_app_country] => US [patent_app_date] => 2012-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 12642 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13538755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10888317 [patent_doc_number] => 08912313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Variants of the promoter of the gap gene coding for glyceraldehyde-3-phosphate dehydrogenase' [patent_app_type] => utility [patent_app_number] => 13/534359 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17424 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799001 [patent_doc_number] => 20150010945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'METHODS AND SYSTEMS FOR TRACKING BIOREMEDIATION PROCESSES' [patent_app_type] => utility [patent_app_number] => 14/127298 [patent_app_country] => US [patent_app_date] => 2012-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2525 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634813 [patent_doc_number] => 20140212922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'TWO PLASMID MAMMALIAN EXPRESSION SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/124383 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6547 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124383 [rel_patent_id] =>[rel_patent_doc_number] =>)